Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

The company also provided an explanation as to why it's delayed reporting.

Cronos Group Commits to Releasing Q4 Results in March

Cronos Group Inc. CRON, +2.91% CRON, +2.57% said late Monday that it was unable to complete its financial statements for fiscal 2019 because of an ongoing review by an internal audit committee, outside lawyers and forensic accountants, according to a filing with the Securities and Exchange Commission.

Cronos unable to complete annual report due to internal review

Aurora Cannabis

HEXO Corp

Tilray Brands

Worries about the global supply chain are sinking these five Canadian pot stocks today.

Why Aurora Cannabis, Cronos Group, HEXO, OrganiGram Holdings, and Tilray Are Getting Hammered Today

Aphria

OrganiGram Holdings Inc.

Aphria, Cronos Group, and OrganiGram Holdings are all screaming bargains relative to their long-term outlook.

Why I Bought These 3 Ridiculously Cheap Pot Stocks

It's now anybody's guess when the figures will be published.

Cronos Group Delays Q4 Results Release

Why marijuana stocks are tanking Monday may be a bit counterintuitive. After all, with major U.S.

Why Cronos and Tilray Have Crumbled

That Q4 update planned for later this week? It's not happening.

Why Cronos Group Stock Is Tumbling Today

Investors will focus on Cronos' (CRON) regular top- and bottom-line numbers, along with its pipeline progress, when it reports Q4 results.

Cronos (CRON) to Report Q4 Earnings: What's in the Cards?

Canopy Growth

These stocks hold the promise of long-term benefits despite the current market downturn for cannabis.

5 Best Cannabis Stocks to Own for the Next Decade

Canadian cannabis company Cronos Group Inc. CRON, -2.59% CRON, -2.88% said Monday it is delaying the release of fourth-quarter earnings that were previously scheduled for Thursday.

Cronos to delay release of fourth-quarter earnings that were due on Thursday

Nasdaq

New Leaf Data Services is compiling the numbers from cannabis business entities in Canada.

Nasdaq Adds Marijuana Price Indexes to Its Platform

Despite their miserable performance, marijuana stocks were in high demand by asset managers in Q4.

Surprise! Billionaire Money Managers Bought These 4 Pot Stocks in the Fourth Quarter

In the latest trading session, Cronos Group (CRON) closed at $7.29, marking a +1.11% move from the previous day.

Cronos Group (CRON) Outpaces Stock Market Gains: What You Should Know

Amplify Alternative Harvest ETF

Here's why cannabis stocks may have bottomed out. Gain exposure through these two leading pot companies or a marijuana-themed ETF.

Cannabis Stocks Appear Ready to Test Recent Highs

Cronos Group reports its fourth-quarter and full-year results on Feb. 27. Owners of CRON stock shouldn’t expect much in the near term.

2020 Could Be the Year Cronos Comes Alive

Altria

Constellation Brands

Brand-name companies are finding little early-stage success in the high-growth cannabis industry.

Let's Face It, Marijuana Equity Investments Have Flopped

The launch of high-margin edibles, vapes, and infused beverages isn't going according to plan.

4 Ways "Cannabis 2.0" Will Be an Early Disappointment in Canada

Scotts Miracle-Gro

After a brutal year in 2019, cannabis stocks are off to another rough start so far in 2020.

7 Cannabis Stocks To Buy, Sell And Hold

Rogers

I'm taking some victory laps and looking at the blowups I successfully predicted last year.

Rogers Corporation, Cronos Group, And High Profile IPOs Could Fall Further In 2020

Cree

The North American cannabis industry is more reliant on China than you probably realize.

Why the Coronavirus Is Bad News for Pot Stocks

Cronos Group (CRON) closed at $7.13 in the latest trading session, marking a -0.7% move from the prior day.

Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know

Arena Pharmaceuticals

Cara Therapeutics

Corbus Pharmaceuticals Holdings

Greenlane Holdings

GW Pharmaceuticals

Marrone Bio Innovations

New Age Beverages

Intec Parent

Psychemedics

SNDL Inc.

Therapix Biosciences

Village Farms International

Zynerba Pharmaceuticals

The cannabis industry has grown in recent months and years, and many companies in the cannabis and health-related industries have been uplisted to reputable U.S. exchanges.

Top Marijuana Stocks on the NASDAQ

Under conventional thinking, CRON stock can’t reach its full potential without the U.S. fully legalizing weed.

Forget Legalization: CBD Is Good Enough for CRON Stock

Cannabis stocks had a huge showing on Wall Street last year. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Cannabis Short Interest Keeps Getting Higher and Higher

Surprisingly, these are two of the most popular marijuana stocks with investors.

The Only 2 Pot Stocks Wall Street Expects to Decline in Value

News for Cronos Group Stock (CRON)